Zobrazeno 1 - 10
of 42
pro vyhledávání: '"W. Stewart Hillis"'
Autor:
Joseph V. De Giovanni, Richard Peatfield, Andrew J. Dowson, Arif Anis Khan, Michael J. Mullen, Trevor Rees, W. Stewart Hillis, W. Lindsay Morrison, Iqbal S. Malik, Christopher Wells, Giles Elrington, Susan Lipscombe, David Hildick-Smith, Keith W. Muir, Anthony Rickards
Publikováno v:
Circulation. 117:1397-1404
Background— Patent foramen ovale (PFO) is prevalent in patients with migraine with aura. Observational studies show that PFO closure resulted in migraine cessation or improvement in ≈80% of such patients. We investigated the effects of PFO closur
Autor:
E Friel, W. Stewart Hillis, Christine D. Holloway, Mary C. Ingram, G. C. Inglis, Lorna Swan, John M. C. Connell, Robert Fraser, Eleanor Davies
Publikováno v:
Clinical Endocrinology. 54:813-817
OBJECTIVE Previous evidence suggests that the efficiency of 11β-hydroxylase is at least partly heritable and also that it may be mildly impaired in essential hypertension. In both cases, assessment of activity was based on the response of 11-deoxyco
Autor:
Arvind Sood, Stuart Watkins, Eileen Peat, Ahmed Mahrous, Alan P. Rae, Hany Eteiba, Jamie Layland, David Carrick, Laura LaSalle, Mitchell Lindsay, Keith G. Oldroyd, Colin Berry, Colum Owens, Miles Behan, Nadeem Ahmed, Stuart Hood, Philippe Généreux, Rebekah Wilson, Margaret McEntegart, Ify Mordi, Caroline Haig, Mark C. Petrie, W. Stewart Hillis, Ian Ford
Publikováno v:
Journal of the American College of Cardiology. 63(20)
Objectives The aim of this study was to assess whether deferred stenting might reduce no-reflow and salvage myocardium in primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI). Background No-reflow is
Publikováno v:
International Journal of Cardiology. 71:129-134
We evaluated the prevalence of left ventricular hypertrophy in elite footballers compared with sedentary controls. A total of 141 elite male professional footballers and 32 healthy sedentary controls were studied. Echocardiographic and demographic va
Changes in systolic time intervals-a non-invasive marker for the haemodynamic effects of sumatriptan
Publikováno v:
British Journal of Clinical Pharmacology. 48:331-335
Aims This study assessed the use of systolic time intervals (STI) as a potential noninvasive marker of the haemodynamic eVects of sumatriptan, a 5HT1 receptor agonist. Methods Twenty-six patients undergoing diagnostic cardiac catheterization particip
Publikováno v:
Clinical Pharmacology & Therapeutics. 66:85-90
Objective To investigate the systemic, pulmonary, and coronary artery effects of eletriptan, a new 5HT1B/1D-agonist in patients undergoing cardiac catheterization. Methods Ten patients (two men and eight women) without significant obstructive coronar
Publikováno v:
International Journal of Cardiology. 127:e167-e169
Greater numbers of children with congenital heart disease are surviving to adulthood. The non-invasive assessment and surveillance of these patients, still based primarily on transthoracic echocardiography, has been significantly enhanced by the adve
Publikováno v:
European Heart Journal. 19:382-386
Coarctationisaheterogeneouslesionwithvariabilityinthedegreeandsiteofobstruction,thepresence of collaterals, and associated cardiac defectsincludingbicuspidaorticvalve,patentductusarteriosus,orventricularseptaldefect.Forthisreasonthereisamarked divers
Autor:
Sven Undeland, Alexander G.G. Turpie, Werner Klein, Jan van der Meer, W. Stewart Hillis, Eric Olaisson, Arnd B. Buchwald, Scott Monrad, Ginés Sanz, Karin Ludwig
Publikováno v:
The American Journal of Cardiology. 80:30E-34E
The safety and efficacy of weight-adjusted, low-molecular-weight heparin (dalteparin) was compared with that of unfractionated heparin during 6 days of treatment in 1,482 patients with unstable angina or non-Q-wave myocardial infarction. Dalteparin,
Autor:
W. Stewart Hillis
Publikováno v:
The American Journal of Cardiology. 80:51E-54E
A "look-and-act" approach, using a strategy of early intervention, and a "watchful waiting" approach, using medical therapy, are compared for the management of patients with unstable coronary artery disease (UCAD). Results from clinical trials are us